Medical Services Cancer Care Clinical Research Find a Location Find a Provider Cancer Care Menu About Our Cancer Care Program Your First Visit Our Cancer Care Team Linear Accelerator Specialty Cancer Care Clinics Cancer Treatments Tristate Gynecological Oncology Clinical Research Power Lunches Hereditary Cancer Program BRCA Testing Neuro-oncology Breast Center Clinical and Support Services Cancer Resource Center Frequent Numbers Palliative Care Cancer Technology Freshstart Smoking Cessation Smoking Cessation Resources Our Commitment The physicians at St. Elizabeth Healthcare are committed to providing the best and most current medical care for all patients. Through this commitment, our patients are eligible for participation in research trials sponsored by the National Cancer Institute and members of the NCI National Clinical Trials Network (NCTN). For questions/additional information about clinical research trials, please contact: Darla Hehman, BSN, RN, CCRC Oncology Research Nurse Phone: (859) 301-5473 Fax: (859) 301-2607 firstname.lastname@example.org Kim Schmidt, MSN, RN Oncology Research Nurse Phone: (859) 301-9418 Fax: (859) 301-2607 email@example.com Additional Resources We encourage patients to explore additional information about clinical trials provided by the National Cancer Institute or the American Cancer Society. Also, The American Cancer Society provides a free, confidential Clinical Trials Matching Service that helps patients, their families and health care workers find cancer clinical trials most appropriate to a patient's medical and personal situation. Follow this NIH Clinical Research Trials and You link for information about the risks and benefits of taking part in a clinical trial, how to find a trial, and questions to ask when considering participation in a trial. Listed below are all of the clinical research trials that are open to patients at St. Elizabeth Healthcare. Breast Cancer ALLIANCE- A011106 Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women ACOSOG-Z11102 Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmesis in Patients with Multiple Ipsilateral Breast Cancers (MIBC) ALLIANCE- A221102 - A Randomized Double-Blind Placebo Controlled Study of Subcutaneous Testosterone in the Adjuvant Treatment of Postmenopausal Women with Aromatase Inhibitor Induced Arthralgia NSABP B-51 - A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy Ovarian Cancer GOG-0225 Can Diet and Physical Activity Modulate Ovarian or Primary Peritoneal Cancer Progression-Free Survival? (Sponsor: Gynecologic Oncology Group) This randomized phase III trial is studying diet and physical activity changes to see how well they work compared with usual care in improving progression-free survival of patients with previously treated stage II, stage III, or stage IV ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer. Uterine Cancer GOG-0238 A Randomized Trial of Pelvic Irradiation with or without Concurrent Weekly Cisplatin in Patients with Pelvic-only Recurrence of Carcinoma of the Uterine Corpus (Sponsor: Gynecologic Oncology Group) This randomized phase II trial is studying radiation therapy and cisplatin to see how well they work compared with radiation therapy alone in treating patients with recurrent endometrial cancer. GOG-0286B A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer” (Sponsor: NRG Oncology) Other GOG-0275 A Phase III Randomized Trial of Pulse Actinomcyin-D versus Multi-day Methotrexate for the Management of Low Risk Gestational Trophoblastic Neoplasia (Sponsor: Gynecologic Oncology Group) This randomized phase III trial is studying the effectiveness of two standard types of chemotherapy treatment and explores factors that may influence quality of life in patients diagnosed with low-risk gestational trophoblastic neoplasia.